New Independent Clinical Study Showcases Safety and Efficacy of GC Aesthetics' PERLE Breast Implant

Contributed by: Business Wire

Logo

Tags

Surgery

Medical Devices

Other Health

Health

Clinical Trials

New Independent Clinical Study

More Like This

GC Aesthetics' PERLE™ Breast Implant features a proprietary surface technology (BioQ™) and GCA’s industry-leading gel technology (Emunomic™ Breast Tissue Dynamic Gel). (Photo: Business Wire)

GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants

GC Aesthetics® Launches YOUTHLY™: A New Era for Breast Implants in China

GC Aesthetics and Bimini Health Tech Form Strategic Partnership to Advance Breast Reconstruction Solutions Globally

GC Aesthetics® Strengthens Board of Directors with Strategic Appointments

AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education

IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community